4.3 Article

Packing the donor heart: Is SherpaPak cold preservation technique safer compared to ice cold storage

Journal

CLINICAL TRANSPLANTATION
Volume 36, Issue 8, Pages -

Publisher

WILEY
DOI: 10.1111/ctr.14707

Keywords

cold storage; heart transplantation; organ preservation; SherpaPak

Ask authors/readers for more resources

This study compared the clinical outcomes of heart transplant patients whose donor hearts were preserved using the SherpaPak controlled cold organ system and the conventional ice storage technique. The results showed that SherpaPak patients had lower Vasoactive Inotropic Score, Primary Graft Dysfunction, and pacing trends, shorter ICU stay, and no severe Primary Graft Dysfunction or mortality.
Introduction The present study aimed to compare the clinical outcomes of heart transplant patients whose donor hearts were preserved with the SherpaPak controlled cold organ system versus the conventional ice storage technique. Methods All patients undergoing heart transplantation at our center between January 2019 and April 2021 were divided into two groups according to the technique used during donor heart preservation and transport. The first group consisted of 34 SherpaPak controlled temperature preservation patients, and the second group consisted of 47 patients where the conventional three bags and ice technique was utilized during organ transportation. The two groups were compared based on demographics, operative details, and postoperative outcomes. Results There were no significant differences between the groups regarding Vasoactive Inotropic Score (VIS), Primary Graft Dysfunction (PGD), and the need for a transient pacer. However, the VIS, PGD, and pacing trends were lower in the SherpaPak patients even though the total ischemic and cardiopulmonary bypass times were significantly longer. Furthermore, SherpaPak patients exhibited a shorter stay in the ICU with no severe PGD and mortality. Conclusion The SherpaPak donor heart preservation provides safe outcomes in heart transplant patients. Further research is needed to utilize this method for longer durations of ischemic time and expand travel distances for organ transportation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Controlled temperatures in cold preservation provides safe heart transplantation results

Macit Bitargil, Osama Haddad, Si M. Pham, Rohan M. Goswami, Parag C. Patel, Samuel Jacob, Magdy M. El-Sayed Ahmed, Juan Carlos Leoni Moreno, Daniel S. Yip, Kevin Landolfo, Basar Sareyyupoglu

Summary: This study aimed to investigate the short-term outcomes of heart transplant patients who underwent SherpaPak system for donor organ preservation. The results showed that using SherpaPak system during heart transplantation is safe and not associated with significant recipient morbidity or mortality.

JOURNAL OF CARDIAC SURGERY (2022)

Article Peripheral Vascular Disease

An interesting finding: What is the relation between aortic enlargement and COVID-19?

Macit Bitargil, Tolga Demir, Hakki Kursat Cetin, Nilufer Bektas, Begum Ozuekren Kasapoglu, Helin El Kilic, Ahmet Ibrahim Balkaya, Ismail Koramaz, Haci Mustafa Ozdemir

Summary: This study compares the diameters of the ascending aorta in COVID-19 patients and COVID-19-free individuals and finds that COVID-19 patients have larger ascending aortic diameters. COVID-19, age, and coronary artery disease are the most influential factors affecting the aortic diameter.

VASCULAR (2023)

Article Chemistry, Multidisciplinary

High-Throughput and Dosage-Controlled Intracellular Delivery of Large Cargos by an Acoustic-Electric Micro-Vortices Platform

Mohammad Aghaamoo, Yu-Hsi Chen, Xuan Li, Neha Garg, Ruoyu Jiang, Jeremy Tian-Hao Yun, Abraham Phillip Lee

Summary: AESOP is a high-throughput non-viral intracellular delivery platform that allows dosage control of large cargos by optimizing delivery efficiency through mechanical shear and electric field expansion of nanopores. With acoustic microstreaming vortices, it enables efficient and uniform delivery of various molecule sizes to cells at a rate of 1 million cells per minute.

ADVANCED SCIENCE (2022)

Article Cardiac & Cardiovascular Systems

Combined cardiac surgery procedures and liver transplant: a single-center experience

Samuel Jacob, Justin H. Nguyen, Magdy M. El-Sayed Ahmed, Ian A. Makey, Osama K. Haddad, Mathew Thomas, Basar Sareyyupoglu, Si M. Pham, Kevin P. Landolfo

Summary: The objective of this study was to assess the outcome of combined cardiac surgery and liver transplant. The results showed that the survival rates were lower in the combined group, but it is still an effective treatment option.

GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Safe heart flush technique during recovery from donors after circulatory death

Magdy M. El-Sayed Ahmed, Kevin P. Landolfo, Samuel Jacob, Basar Sareyyupoglu, Mathew Thomas, Si M. Pham, Ian A. Makey

Summary: This study assessed the efficacy of using a Foley catheter to flush the heart in donation after circulatory death donors, demonstrating that this method was efficient and fast.

JOURNAL OF CARDIAC SURGERY (2022)

Article Immunology

Regression of Tricuspid Valve Regurgitation After Lung Transplant: A Single-Center Experience

Samuel Jacob, Magdy M. El-Sayed Ahmed, Osama K. Haddad, David Orlando, Carolyn Landolfo, Mathew Thomas, Ian A. Makey, Basar Sareyyupoglu, Kevin Landolfo, Si M. Pham

Summary: This study evaluated the natural course of tricuspid regurgitation (TR) among patients who did not undergo tricuspid valve repair (TVR) at the time of lung transplant. The results showed that the severity of TR improved or remained unchanged in most patients after transplant, indicating that TVR may not be necessary for most lung transplant recipients.

TRANSPLANTATION PROCEEDINGS (2022)

Review Cardiac & Cardiovascular Systems

Accelerated LVAD pump thrombosis in COVID-19 patient: Case report and mini review

Ishaq J. Wadiwala, Pankaj Garg, Mohammad Alomari, Mohamed S. Elawady, Emad Alamouti-Fard, Lekhya Raavi, Nargis Mateen, Fazal Khan, Md Walid Akram Hussain, Si M. Pham, Samuel Jacob

Summary: COVID-19 infection increases the risk of LVAD thrombosis in heart failure patients, leading to worse outcomes for those infected.

JOURNAL OF CARDIAC SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Short-term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device

Osama Haddad, Basar Sareyyupoglu, Rohan M. Goswami, Macit Bitargil, Parag C. Patel, Samuel Jacob, Magdy M. El-Sayed M. Ahmed, Juan Carlos Leoni Moreno, Daniel S. Yip, Kevin Landolfo, Si M. Pham

Summary: This study aimed to investigate the outcomes of heart transplant patients supported with Impella 5.5 temporary mechanical circulatory support. The results showed that the use of the Impella 5.5 device provided superior hemodynamic support, improved renal function, and favorable pulmonary and right ventricular function in heart transplant recipients.

ESC HEART FAILURE (2023)

Article Surgery

Evolution of HLA-sensitization according to immunosuppressive therapy management among kidney transplant patients returning to dialysis between 2008 and 2019: A French retrospective study

Kevin Ferrari, Alice Aarnink, Carole Ayav, Luc Frimat, Cecile Couchoud, Benoit Audry, Corinne Antoine, Sophie Girerd

Summary: Continuation of immunosuppressive therapy after kidney allograft failure is associated with less change in HLA-sensitization and does not increase patient mortality.

CLINICAL TRANSPLANTATION (2024)

Article Surgery

Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension

Sandeep Sainathan, John Ryan, Leonardo Mullinari, Pablo Sanchez

Summary: Patients undergoing lung transplantation for pulmonary venous-occlusive disease (PVOD) had better initial survival compared to those with primary pulmonary hypertension (PPHTN), but this advantage disappeared after 1 year. The use of donation after circulatory death donors was associated with lower short-term survival rates.

CLINICAL TRANSPLANTATION (2024)